Unique ID issued by UMIN | UMIN000020738 |
---|---|
Receipt number | R000023928 |
Scientific Title | Development of a new intrapartum fetal monitoring technique using a finger-mounted fetal tissue oximeter: a multicenter study |
Date of disclosure of the study information | 2016/02/03 |
Last modified on | 2018/05/26 09:00:36 |
Development of a new intrapartum fetal monitoring technique using a finger-mounted fetal tissue oximeter: a multicenter study
Development of a finger-mounted fetal tissue oximeter
Development of a new intrapartum fetal monitoring technique using a finger-mounted fetal tissue oximeter: a multicenter study
Development of a finger-mounted fetal tissue oximeter
Japan |
Pregnant women over 36 weeks of gestation and who will undergo transvaginal delivery
Obstetrics and Gynecology |
Others
NO
To investigate the effectiveness of the examiner's finger-mounted fetal tissue oximeter for fetal monitoring in pregnant women during intrapartum.
Safety,Efficacy
To establish standard values for fetal tissue oxygen saturation and total hemoglobin index during the first and second stages of labor and the newborn's tissue oxygen saturation and total hemoglobin index after birth.
1. Incidence of abnormal fetal heart rate monitoring in newborns whose umbilical cord artery blood pH is >7.25 and the Apgar score is >8.
2. Incidence of normal fetal tissue oxygen saturation and total hemoglobin index in patients who fulfill a key secondary outcome of 1.
3. Incidence of normal fetal heart rate monitoring in newborns whose umbilical cord artery blood pH is <7.25 and the Apgar score is <8.
4. Incidence of abnormal fetal tissue oxygen saturation and total hemoglobin index in patients who fulfill a key secondary outcome of 3.
5. Fetal tissue oxygen saturation and total hemoglobin index in patients with abnormal fetal heart rate.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Device,equipment |
Finger-mounted fetal tissue oximeter
Not applicable |
Not applicable |
Female
1. Pregnant women over 36 weeks of gestation and who will undergo transvaginal delivery.
2. Patients who have voluntarily provided written consent to participate in this trial, after having been thoroughly briefed and informed of the nature of the trial [if the patient is <20 years old, written consent must be obtained from the husband (>20 years) or a parent].
1. Multiple pregnancies
2. Previously underwent myomectomy and/or cesarean section
3. Fetal malpresentation
4. Malposition of the placenta
300
1st name | |
Middle name | |
Last name | Naohiro Kanayama |
Hamamatsu University School of Medicine
Department of Obstetrics and Gynecology
1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan
053-435-2309
kanayama@hama-md.ac.jp
1st name | |
Middle name | |
Last name | Toshiyuki Uchida |
Hamamatsu University School of Medicine
Department of Obstetrics and Gynecology
1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan
053-435-2309
utty@hama-med.ac.jp
Hamamatsu University School of Medicine
Grant-in-Aid for Scientific Research (C)
Japanese Governmental office
NO
2016 | Year | 02 | Month | 03 | Day |
Unpublished
No longer recruiting
2016 | Year | 01 | Month | 06 | Day |
2016 | Year | 01 | Month | 06 | Day |
2018 | Year | 05 | Month | 31 | Day |
2018 | Year | 05 | Month | 31 | Day |
2018 | Year | 05 | Month | 31 | Day |
2018 | Year | 06 | Month | 16 | Day |
2016 | Year | 01 | Month | 26 | Day |
2018 | Year | 05 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023928